Skip to content

Evaluation of antihypertensive effect on elderly morning hypertension under guidance of hemodynamic phenotyping

Evaluation of antihypertensive effect on elderly morning hypertension under guidance of hemodynamic phenotyping

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072763
Enrollment
Unknown
Registered
2023-06-25
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Intervention group:Report on hemodynamic testing (HDpro CHMP1505W). Hemodynamic abnormality were judged as the corresponding index of hemodynamic testing with 1 standard deviation higher than the norm
2.Hyper-resistance, including: 1)High arterial/aortic Stiffness Index: add calcium channel antagonists or increase doses
2)High resistance of peripheral blood vessels: add ACEI or angiotensin-converting enzyme inhibitorARB, angiotensin receptor blocker or increase doses
3.Hypervolemia: with higher thoracic blood volume standing/supine ration: add diuretic or increase doses
Combined treatment recommended as multiple abnormality exist.
Intervention group:Doctors adjust antihypertension therapy based on the drug selection process of the 2016 Chinese Hypertension Prevention and Treatment Guidelines and their own clinical experience.

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1.=60 years old 2.The diagnosed hypertension patients and were currently on less than three kinds of antihypertensive medications for = 4 weeks with same prescription. Clinic blood pressure did not achieve blood pressure targets, and ambulatory Blood Pressure indicated early morning hypertension: 1)Clinical blood pressure: SBP=140mmHg and/or DBP=90mmHg 2)Ambulatory blood pressure: morning (2 hours after waking up) blood pressure-average SBP=135 and/or average DBP=85mmHg 3.Signed informed consent

Exclusion criteria

Exclusion criteria: 1.SBP(Systolic blood pressure)=180mmHg or DBP (Diastolic blood pressure)=110mmHg(clinical blood pressure); 2. Patients with instability haemodynamies such as serious main valve regurgitation 3.Severe arrhythmia such as atrial fibrillation 4.Severe pleural effusion; 5.Height 230 cm / weight 230kg; 6.With severe liver and kidney diseases, infections, tumors, malnutrition 7.With severe cardiac insufficiency and renal insufficiency, cardiovascular events such as acute myocardial infarction, acute stroke 8.Hypertension emergency 9.Secondary hypertension Patients who are contraindicated to first-line antihypertensive drugs

Design outcomes

Primary

MeasureTime frame
Reduced systolic blood pressure;

Secondary

MeasureTime frame
Uncontrolled rate of hypertension;

Countries

China

Contacts

Public ContactYu Wei

Zhejiang Hospital

yuweipost@163.com+86 571 8796 4761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026